Lead acid batteries producer Monbat shareholders will vote BGN 0.19 DPS at a general shareholders meeting scheduled for 25th June, 2018, the Company announced in a regulatory filing to the Bulgarian Stock Exchange.
ELANA Agrocredit successfully completed its capital increase raising a total of BGN 19.5m, the Company reported in a regulatory filing. The minimum required for success of the offering was set at 10 mln. shares subscribed (BGN 1.10 per share).
Leading generic pharmaceuticals producer Sopharma proposed a BGN 0.11 dividend per share (DPS), the Company disclosed in a filing to the Trade Registry. This comes very short of ELANA Trading Research team BGN 0.12 DPS estimate.
Steel radiator producer Korado proposed BGN 0.26 DPS and expects new contracts from Germany, the Company announced at meeting with investors on 29th March, 2018 where it presented its audited results for 2017.
The biggest vertically integrated human health pharmaceutical group in Bulgaria Sopharma booked record performance in 2017 with the top line hitting BGN 1bn and best EBITDA ever on strong organic and M&A driven growth. Individual bottom line margins healthy above historical and peer averages at 20%+ as cost and group optimization kicked in.
ELANA Agrocredit’s (0EA BU) shareholders approve BGN 0.0858 DPS, the Company announced in a regulatory notice following the shareholders meeting held March 15th, 2018. The latter dividend yields 7% at current market quotes.
Shareholders of Bulgaria’s leading generic drugs producer Sopharma (3JR BU) and Unipharm (59X BU) approve merger, according to а regulatory note from the two extraordinary shareholders’ meetings held on 23rd Feb 2018.
Bulgaria’s only steel panel radiator producer Korado Bulgaria strengthened its financial results in FY2017, confirming its position of a wellmanaged and profitable company in a rather mature sector with strong competition from European and global peers – this is what ELANA Trading analysts say in their updated corporate profile for the Company.
bg
